Latest COVID-research (VI) – NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 3 August edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

Latest COVID-research (V) – NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 27 July edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

EUI Data Portal

While we will continue to update this page with news items the blog format is not the most convenient for finding data. All the data on these pages can now be found in a more organized form in the EUI Data Portal a long-term project designed to make available covid-19 related data for social science researchers.

Underestimated option? Repurposing drugs for treatment of COVID-19

With the main focus on finding a COVID-19 vaccine, policy makers and industry have paid less attention to the development of therapeutics. Within this field, Susan Athey, Rena Conti, Richard Frank and Jonathan Gruber show, the repurosing of existing drugs for treatment of COVID-19 diserves special attention, as the safety of these drugs is already established and their manufacturing well understood. Given that this path is less attractive for private sector investors in comparison to the development of new drugs that can be sold at higher prizes, the authors propose a three-part plan for the U.S. government to incentivice investment and studies into repurposing drugs for COVID-19 treatment. The plan suggests among other things public-private partnerships, clinical development networks and premiums paid for successfully bringing repurposed drugs to the market.

Latest COVID-research (IV) -NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 13 July edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

Latest COVID-research (III) -NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 6 July edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

Latest COVID-research (II) -NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 29 June edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

Latest COVID-research (I) -NBER Working Papers

This thread lists COVID-related papers recently published in the Working Papers series of the National Bureau of Economic Research (United States).

From the 22 June edition:

NOTE: The NBER Working Papers series publishes early findings of ongoing research to encourage discussion and collect suggestions for revisions. Papers are neither peer reviewed nor endorsed by the NBER Board of directors.

Uncertainty and decision-making during the COVID-19 crisis

COVID-19 has become a major challenge to policymaking. In a context of high uncertainty, rapidly changing circumstances and a highly fluid base of evidence and scientifically-grounded predictions – policy-makers have to take decisions on which human lives and the economy depend. Using ideas and constructs from modern decision theory, the authors of this paper propose ways to arrive at decisions that remain valid for a wide range of futures and keep options open, while allowing for a responsible and transparent policy-making process.

Rotation as Contagion Mitigation

In their new paper, Jeffrey Ely, Andrea Galeotti and Jakub Steiner study how to organize workforce rotation in order to minimize the risk of contagion. Frequent rotation may be advisable if an organization is able to detect/react to infections quickly. Infrequent rotation is optimal when organisations react slowly.